Determinants of neoadjuvant chemotherapy use in muscle-invasive bladder cancer

Purpose: Cisplatin-based neoadjuvant chemotherapy (NAC) followed by radical cystectomy (RC) is standard of care for muscle-invasive bladder cancer (MIBC). However, NAC is used in less than 20% of patients with MIBC. Our goal is to investigate factors that contribute to underutilization NAC to facili...

Full description

Bibliographic Details
Main Authors: Filipe LF. Carvalho, Alexander Zeymo, Jillian Egan, Colleen H. Kelly, Chaoyi Zheng, John H. Lynch, Jonathan Hwang, Lambros Stamatakis, Ross E. Krasnow, Keith J. Kowalczyk
Format: Article
Language:English
Published: Korean Urological Association 2020-07-01
Series:Investigative and Clinical Urology
Subjects:
Online Access:https://www.icurology.org/Synapse/Data/PDFData/2020ICU/icu-61-390.pdf

Similar Items